
Location: Oxford, UK
Job Type: Full Time
Work Pattern: Hybrid
Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and a commercial presence across the US, APAC and Europe.
Oxford Nanopore employs experts from a wide range of disciplines, including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a strong track record of bringing disruptive technologies to market.
Oxford Nanopore's sequencing platform is the only technology that offers real-time analysis for rapid insights in fully scalable formats, from pocket-sized devices to population-scale solutions. It can analyse native DNA or RNA and sequence fragments of any length, delivering short to ultra-long read lengths.
Our goal is to enable the analysis of any living thing, by anyone, anywhere. We provide real-time nanopore-based DNA/RNA sequencing technology that is accessible, easy to use and fully scalable to meet any requirement.
The core objective of this role is to maintain, support and implement new product introductions and product changes, from early access through to full production and eventual product decline. This includes managing all component parts, assembly levels and finished goods across all business entities, while ensuring standard cost roll-ups and transfer pricing are correctly implemented.
The successful candidate will ensure that new product launches and product changes within the Company's ERP systems are managed through a controlled process. This will support the successful transition of finished goods sales, internal and external manufacturing of assemblies, and the purchasing of raw materials, while minimising inaccuracies in standard cost roll-ups and transfer pricing.
A strong working knowledge of the Company's ERP systems is essential to ensure processes are followed correctly. The role will also involve resolving product data challenges within the ERP systems and supporting continuous process improvements.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed solely on their merits, qualifications and ability to perform the duties of the role.
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.